PEAK BIO INC (PKBO) Stock Price, Quote, News and Overview
NASDAQ:PKBO - Nasdaq - US70470P1084 - Common Stock - Currency: USD
PKBO Quote, Performance and Key Statistics
2.56
-0.96 (-27.27%)
The current stock price of PKBO is 2.56 USD. In the past month the price decreased by -53.45%.
PKBO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.3 | 331.94B | ||
| AMGN | AMGEN INC | 13.6 | 151.78B | ||
| GILD | GILEAD SCIENCES INC | 13.83 | 133.20B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 114.27B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.7 | 55.98B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 41.53B | ||
| ARGX | ARGENX SE - ADR | 97.26 | 34.15B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.69 | 28.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.32B | ||
| NTRA | NATERA INC | N/A | 22.66B | ||
| INSM | INSMED INC | N/A | 18.91B | ||
| BIIB | BIOGEN INC | 8.1 | 18.77B |
Related stock screener links
About PKBO
Company Profile
Peak Bio Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Palo Alto, California. The company went IPO on 2021-01-28. Peak Bio Inc. is focused on developing drugs to treat oncology and inflammatory diseases. The firm's pipeline of inflammatory therapeutic candidates is led by PHP-303, which is in Phase II ready in alpha1 anti-trypsin deficiency (AATD) and works by inhibiting a bioactive form of Neutrophil Elastase (NE). Its pipeline also includes an antibody drug conjugate platform focused on developing therapies for oncology indications. Its lead product candidate, PHP- 303 is an oral, once daily, potent, selective small molecule inhibitor of NE designed to inhibit the bioactive form of NE that the Company is developing for the treatment of AATD, a life-threatening rare, genetic condition that results in severe debilitating diseases, including early-onset pulmonary emphysema. Its proprietary toxin, Thailanstatin (PH-1), a spliceosome modulator, is being used to generate its first pipeline of ADC product candidates to address unmet needs in cancer patients.
Company Info
PEAK BIO INC
3350 W Bayshore Rd. Suite 100
Palo Alto CALIFORNIA US
Employees: 0
Phone: 16505499103.0
PEAK BIO INC / PKBO FAQ
What is the stock price of PEAK BIO INC today?
The current stock price of PKBO is 2.56 USD. The price decreased by -27.27% in the last trading session.
What is the ticker symbol for PEAK BIO INC stock?
The exchange symbol of PEAK BIO INC is PKBO and it is listed on the Nasdaq exchange.
On which exchange is PKBO stock listed?
PKBO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PEAK BIO INC stock?
7 analysts have analysed PKBO and the average price target is 15.3 USD. This implies a price increase of 497.66% is expected in the next year compared to the current price of 2.56. Check the PEAK BIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PEAK BIO INC worth?
PEAK BIO INC (PKBO) has a market capitalization of 50.64M USD. This makes PKBO a Micro Cap stock.
How many employees does PEAK BIO INC have?
PEAK BIO INC (PKBO) currently has 0 employees.
Should I buy PEAK BIO INC (PKBO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PKBO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PKBO, evaluating the profitability, health, valuation and growth aspects
- PEAK BIO INC (PKBO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PEAK BIO INC (PKBO) Sales and EPS estimates to see what analysts future expectations are.
- PEAK BIO INC (PKBO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PEAK BIO INC (PKBO) Insider and Institutional Ownership to learn about the owners and their transactions.
- PEAK BIO INC (PKBO) Stock Chart to make your own analysis
- PEAK BIO INC (PKBO) Latest news and press-releases to stay up to date.
Does PEAK BIO INC (PKBO) stock pay dividends?
PKBO does not pay a dividend.
PKBO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PKBO.
PKBO Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PKBO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to PKBO. The Buy consensus is the average rating of analysts ratings from 7 analysts.